Consolidated income statement
For the year ended 31 December
| Note | 2010 | 2009 |
Revenues | 406,595 | 305,022 | |
Cost of revenues | (26,071) | (25,471) | |
Gross profit | 380,524 | 279,551 | |
Operating expenses |
| ||
Research and development | (139,750) | (112,215) | |
Sales and marketing | (70,108) | (61,723) | |
General and administrative | (63,707) | (59,999) | |
Total operating expenses, net | (273,565) | (233,937) | |
Profit from operations | 106,959 | 45,614 | |
Investment income | 3,634 | 1,788 | |
Interest payable and similar charges | (566) | (143) | |
Profit before tax | 110,027 | 47,259 | |
Tax | (24,053) | (6,820) | |
Profit for the year | 85,974 | 40,439 | |
Earnings per share |
| ||
Basic and diluted earnings | 85,974 | 40,439 | |
Number of shares (‘000) |
| ||
Basic weighted average number of shares | 1,313,186 | 1,266,624 | |
Effect of dilutitive securities: Employee incentive schemes | 39,007 | 34,026 | |
Diluted weighted average number of shares | 1,352,193 | 1,300,650 | |
Basic EPS | 6.5p | 3.2p | |
Diluted EPS | 6.4p | 3.1p |
All activities relate to continuing operations. All the profit for the year is attributable to the equity holders of the parent. The Company has opted to present its own accounts under UK GAAP. The accompanying notes are an integral part of the financial statements.
Details of dividends paid and proposed are in notes 7 and 27 of the financial statements respectively.